News about Research
A new study led by the Clínic-IDIBAPS reveals that skin temperature can help monitor bipolar disorder
An international team headed by the IDIBAPS Bipolar and Depressive Disorders research group shows that skin temperature measured with a smartwatch...
Open day at IDIBAPS 2025
IDIBAPS, the research institute affiliated with Hospital Clínic de Barcelona, is organizing an open day in its laboratories on November 19 and 20 a...
IDIBAPS researchers detail the role played by certain microRNAs in the development of liver cirrhosis
Two studies led by the IDIBAPS Liver Vascular Biology group, located at Esther Koplowitz Centre, headed by Jordi Gracia-Sancho, reveal the key role...
IDIBAPS endorses Comunitat Hipàtia’s recommendations for inclusive health research communication
IDIBAPS has taken a step forward in its commitment to equality and diversity by adopting the recommendations for inclusive communication in health...
A Clínic-IDIBAPS study identifies the brain circuits conditioning fear in over 2,000 people
A team from the Clínic-IDIBAPS has led a study of the international consortium of neuroimage ENIGMA that has allowed us a better understanding of w...
Dr Marta Pazos, new director of the Clínic Ophthalmology Institute
Dr Marta Pazos has been appointed director of the Clínic Ophthalmology Institute (ICOF) at the Hospital Clínic Barcelona. A glaucoma specialist, sh...
TherVacB Project Begins Patient Trial to Advance Curative Strategy for Chronic Hepatitis B
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and cont...
Josep Dalmau receives the 2025 National Research Award in Medicine and Health Sciences
The Ministry of Science, Innovation and Universities announced this Friday the winners of the 2025 National Research Awards, one of the most presti...
A key mechanism discovered in mantle cell lymphoma opens the door to new treatments
An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.
